Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and IL-2 in Metastatic Renal Cell Carcinoma
NCT00609401Phase 2Completed
- Start
- Nov 2006
- Primary completion
- May 2007
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in renal cell carcinoma (RCC). Started Nov 2006; status: completed.
02
Drugs
aldesleukin
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00609401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609401.